Lv5
808 积分 2021-09-06 加入
Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages
1天前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
1天前
已完结
CAR therapies: development, design, and implementation
1天前
已完结
Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells
2天前
已完结
Extrachromosomal DNA replication and maintenance couple with DNA damage pathway in tumors
2天前
已完结
Chemical reprogramming of human somatic cells to pluripotent stem cells
3天前
已完结
Human natural killer cell expansion in vitro using mitomycin-C treatment as an alternative to irradiation of modified K562 feeder cells
4天前
求助中
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
6天前
已完结
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
10天前
已完结
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
10天前
已完结
皖公网安备34019202002308
